v3.20.2
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock Outstanding
Treasury Shares at Cost
Par Value and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2018 $ 24,718   $ (6) $ 38,010 $ (332) $ (12,954)
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2018   850,180,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 1,847         1,847
Other comprehensive (loss) income (481)       (481)  
Stock-based compensation 264     264    
Exercise of stock options 1     1    
Exercise of stock options (in shares)   51,135        
Stock issued for employee stock purchase plan 69     69    
Stock issued for employee stock purchase plan (in shares)   1,135,801        
Issuance of vested restricted stock units (in shares)   4,550,115        
Issuance of restricted stock awards (in shares)   (20,769)        
Shares withheld related to net share settlement of stock awards and stock options (104)     (104)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,420,662)        
Transfer RSU from NQDC plan     (2) 2    
Transfer RSU to NQDC plan (in shares)   (23,295)        
Prior year Retained Earnings 653         653
Balance, end of period at Jun. 30, 2019 26,967   (8) 38,242 (813) (10,454)
Common stock outstanding, ending balance (in shares) at Jun. 30, 2019   854,452,642        
Balance, beginning of period at Mar. 31, 2019 26,181   (5) 38,100 (521) (11,393)
Common stock outstanding, beginning balance (in shares) at Mar. 31, 2019   854,380,118        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 939         939
Other comprehensive (loss) income (292)       (292)  
Stock-based compensation 143     143    
Exercise of stock options (in shares)   19,261        
Stock issued for employee stock purchase plan (in shares)   (36,710)        
Issuance of vested restricted stock units (in shares)   206,143        
Issuance of restricted stock awards (in shares)   (20,769)        
Shares withheld related to net share settlement of stock awards and stock options $ (4)     (4)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (56,041)        
Distribution from NQDC plan     (3) 3    
Distribution from NQDC plan (in shares) (39,360)          
Balance, end of period at Jun. 30, 2019 $ 26,967   (8) 38,242 (813) (10,454)
Common stock outstanding, ending balance (in shares) at Jun. 30, 2019   854,452,642        
Balance, beginning of period at Dec. 31, 2019 $ 28,789   (8) 38,498 (868) (8,833)
Common stock outstanding, beginning balance (in shares) at Dec. 31, 2019 856,905,400 856,905,400        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 1,061         1,061
Other comprehensive (loss) income (790)       (790)  
Executive put option 1     1    
Executive put option (in shares)   (342,000)        
Stock-based compensation 424     424    
Exercise of stock options 15     15    
Exercise of stock options (in shares)   311,587        
Stock issued for employee stock purchase plan 83     83    
Stock issued for employee stock purchase plan (in shares)   1,246,304        
Issuance of vested restricted stock units (in shares)   8,912,304        
Shares withheld related to net share settlement of stock awards and stock options (279)     (279)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (3,055,034)        
Transfer RSU from NQDC plan     (4) 4    
Transfer RSU to NQDC plan (in shares)   (35,877)        
Shares issued in secondary offering 17,216     17,216    
Shares issued in secondary offering (in shares)   173,564,426        
Shares repurchased from SoftBank [1] $ (16,990)          
Shares repurchased from SoftBank (in shares) [1] (173,564,426)          
Merger consideration $ 33,533     33,533    
Purchase price consideration (in shares)   373,396,310        
Prior year Retained Earnings (67)         (67)
Balance, end of period at Jun. 30, 2020 $ 62,996   (12) 72,505 (1,658) (7,839)
Common stock outstanding, ending balance (in shares) at Jun. 30, 2020 1,237,338,994 1,237,338,994        
Balance, beginning of period at Mar. 31, 2020 $ 28,977   (11) 38,597 (1,660) (7,949)
Common stock outstanding, beginning balance (in shares) at Mar. 31, 2020   861,128,106        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 110         110
Other comprehensive (loss) income 2       2  
Stock-based compensation 272     272    
Exercise of stock options 14     14    
Exercise of stock options (in shares)   262,394        
Stock issued for employee stock purchase plan (in shares)   (13)        
Issuance of vested restricted stock units (in shares)   4,157,095        
Shares withheld related to net share settlement of stock awards and stock options $ (138)     (138)    
Shares withheld related to net share settlement of stock awards and stock options (in shares)   (1,564,635)        
Distribution from NQDC plan     (1) 1    
Distribution from NQDC plan (in shares)   (40,263)        
Shares issued in secondary offering       17,216    
Shares issued in secondary offering (in shares)   173,564,426        
Shares repurchased from SoftBank [1]       (16,990)    
Shares repurchased from SoftBank (in shares) [1] (173,564,426)          
Merger consideration       33,533    
Purchase price consideration (in shares)   373,396,310        
Balance, end of period at Jun. 30, 2020 $ 62,996   $ (12) $ 72,505 $ (1,658) $ (7,839)
Common stock outstanding, ending balance (in shares) at Jun. 30, 2020 1,237,338,994 1,237,338,994        
[1] In connection with the SoftBank Monetization (as defined below) we received a payment of $300 million from SoftBank (as defined below). This amount, net of tax, was treated as a reduction of the purchase price of the shares acquired from SoftBank and was recorded as Additional paid-in capital.